Skip to main content
. 2015 Nov 10;10(11):e0142081. doi: 10.1371/journal.pone.0142081

Table 1. Patient Demographics 1 .

Placebo SRT2104 Dose
Parameter (N = 7)
250 mg (N = 9) 500 mg (N = 12) 1000 mg (N = 11)
Age (Years)
N 7 9 12 11
Mean (SD) 51.4 (14.9) 40.6 (16.1) 49.3 (14.4) 44.6 (13.6)
Median (Min, Max) 50 (27, 72) 45 (19, 60) 52 (26, 68) 43 (26, 65)
Sex, n (%)
n 7 9 12 11
Women: 1 (14) 3 (33) 0 5 (45)
Men: 6 (86) 6 (67) 12 (100) 6 (55)
Race, n (%)
n 7 9 12 11
White 6 (86) 7 (78) 10 (83) 10 (91)
Black 1 (14) 2 (22) 0 1 (9)
Asian 0 0 1 (8) 0
Other 0 0 1 (8) 0
Ethnicity, n (%)
n 7 9 12 11
Hispanic or Latino 0 0 3 (25) 2 (18)
Not Hispanic or Latino 7 (100) 9 (100) 9 (75) 9 (82)
Height (cm)
n 7 9 10 11
Mean (SD) 172 (7.99) 176 (6.86) 177 (7.81) 173 (7.72)
Median (Min, Max) 175 (155, 178) 178 (165, 185) 177 (160, 185) 175 (160, 188)
Weight (kg)
n 7 9 12 11
Mean (SD) 92.7 (11.2) 105 (24.5) 88.1 (15.6) 84.9 (27.8)
Median (Min, Max) 91.9 (77, 104) 105 (74, 156) 81.1 (70, 116) 81.6 (62, 158)
BMI (kg/m 2 ) 1
n 7 9 10 11
Mean (SD) 31.5 (3.81) 33.4 (5.57) 27.4 (4.40) 28.6 (9.63)
Median (Min, Max) 32.9 (24, 36) 33.4 (26, 45) 25.9 (23, 35) 25.8 (20, 55)

1 BMI–body mass index.